LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

Search

GoodRx Holdings Inc

Open

SectorGezondheidszorg

4.4 -0.9

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.39

Max

4.5

Belangrijke statistieken

By Trading Economics

Inkomsten

1.8M

13M

Verkoop

100K

203M

K/W

Sectorgemiddelde

47.222

35.724

Winstmarge

6.324

Werknemers

738

EBITDA

23M

50M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+23.79% upside

Dividenden

By Dow Jones

Volgende Winsten

6 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-131M

1.5B

Vorige openingsprijs

5.3

Vorige sluitingsprijs

4.4

Nieuwssentiment

By Acuity

50%

50%

172 / 372 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

GoodRx Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 aug 2025, 13:52 UTC

Belangrijke Marktbewegers

GoodRx Partners With Novo Nordisk to Lower Cost of Weight-Loss Drugs

Peer Vergelijking

Prijswijziging

GoodRx Holdings Inc Prognose

Koersdoel

By TipRanks

23.79% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 5.36 USD  23.79%

Hoogste 7 USD

Laagste 3.4 USD

Gebaseerd op 14 Wall Street-analisten die 12-maands prijsdoelen bieden voor GoodRx Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

14 ratings

7

Buy

6

Hold

1

Sell

Technische score

By Trading Central

3.675 / 4.65Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Weak Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

172 / 372 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over GoodRx Holdings Inc

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.